Study types
- article 7
- dataset 2
- other 2
Frequent coauthors
- André Koch 11
- B. Krämer 11
- Christoph Trautwein 11
- Sisi Deng 11
- Tony Reinsperger 11
- Gyuntae Bae 11
- Jürgen Andress 11
- James Sklut 11
- Lukas Schimunek 11
- Oscar Millet 11
Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.
Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.
Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.
Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.
Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.
Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.
Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.
Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.
Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…
BACKGROUND: Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy controls. We ev…
Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…